TY - JOUR
T1 - Evaluation of medication compliance for secondary prevention of acute coronary syndrome
AU - Gill, Dalvir
AU - Feldman, Elizabeth A.
AU - Liu, Kan
N1 - Publisher Copyright:
© 2018, Taylor and Francis Inc. All rights reserved.
PY - 2018/1/22
Y1 - 2018/1/22
N2 - To prevent recurrence of acute coronary syndrome (ACS), national practice guidelines recommend use of five-drug combination therapy. Our study assessed the proportion of patients discharged on all five medications following ACS and determined reasons for nonadherence. A retrospective, single-center chart review was conducted at a tertiary academic medical center. Patients 18 years and older who were admitted to the cardiac care unit with a diagnosis of ACS between January 2013 and January 2015 were included. Overall, 200 patients were screened and 155 were included in the study. Half of the patients received all guideline-recommended classes of pharmacological agents at discharge. The other half-78 patients-did not receive the five-drug combination, of whom 48 (62%) had reasons documented for nonadherence. Our study’s findings suggest that rates of adherence need to improve given the clear benefits of these medications.
AB - To prevent recurrence of acute coronary syndrome (ACS), national practice guidelines recommend use of five-drug combination therapy. Our study assessed the proportion of patients discharged on all five medications following ACS and determined reasons for nonadherence. A retrospective, single-center chart review was conducted at a tertiary academic medical center. Patients 18 years and older who were admitted to the cardiac care unit with a diagnosis of ACS between January 2013 and January 2015 were included. Overall, 200 patients were screened and 155 were included in the study. Half of the patients received all guideline-recommended classes of pharmacological agents at discharge. The other half-78 patients-did not receive the five-drug combination, of whom 48 (62%) had reasons documented for nonadherence. Our study’s findings suggest that rates of adherence need to improve given the clear benefits of these medications.
UR - http://www.scopus.com/inward/record.url?scp=85047017657&partnerID=8YFLogxK
U2 - 10.1080/08998280.2017.11930208
DO - 10.1080/08998280.2017.11930208
M3 - Article
AN - SCOPUS:85047017657
SN - 0899-8280
VL - 30
SP - 410
EP - 415
JO - Baylor University Medical Center Proceedings
JF - Baylor University Medical Center Proceedings
IS - 4
ER -